Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

ReGen to FDA: ‘Thanks, But No Thanks’

March 22, 2011 By Bio-Medicine.Org

WASHINGTON, March 22, 2011 /PRNewswire/ — ReGen Biologics, Inc.
(ReGen), manufacturer of the popular and successful Menaflex
Collagen Meniscus implant, today declined the U.S. Food and Drug
Administration’s (FDA) offer of a hearing under 21 CFR Part 16
before the agency formalizes its decision to rescind clearance of
the device.

According to ReGen Chair and CEO Gerald E. Bisbee, Jr., Ph.D.,
the company’s experience with the FDA over the past six years makes
it clear that any such hearing would be futile. “The safety and
effectiveness issues surrounding the clearance of our device were
settled years ago at a November 14, 2008 Advisory Panel meeting.
 The independent experts on that Panel were completely in
Menaflex’s favor,” he said.  “The only issues that require
remediation are the blatantly arbitrary and unfair processes of the
FDA, and those aren’t on the table in a Part 16 review.
 Enough is enough.”

ReGen’s Menaflex device is a resorbable surgical mesh used in
meniscus surgeries to reinforce damaged or weakened meniscal soft
tissues, which provides a scaffold for replacement by a patient’s
own soft tissue.  It was approved in Europe in 2000 under the
most stringent review classification for use in medial meniscus
injuries, and in 2006 for lateral meniscus injuries.  To date,
the device has been used successfully in over 3000 European
surgeries, with no safety issues.  In fact, a recent
independent publication from a prestigious European academic center
shows that 10 years after surgery, Menaflex patients show
superiority to patients receiving the standard of care, partial
meniscectomy.

In December 2008, following 3 years of review under the 510(k)
process including input from an Advisory Panel of independent
experts, the FDA ruled that the product is as safe and effective as
other surgical meshes and cleared it for use by surgeons in the
U.S.  Two years later, following a change in top management at
FD

‘/>”/>

SOURCE

Related Articles Read More >

TE Connectivity opens global medical device prototyping center in Ireland
Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech